From Casetext: Smarter Legal Research

Pliva v. Mensing

U.S.
Dec 10, 2010
562 U.S. 1104 (2010)

Summary

In Mensing, the Supreme Court held that similar provisions of Minnesota and Louisiana product liability law "require a drug manufacturer that is or should be aware of its product's danger to label that product in a way that renders it reasonably safe."

Summary of this case from Couick v. Wyeth, Inc.

Opinion

No. 09–993.

12-10-2010

PLIVA, INC., et al., petitioners, v. Gladys MENSING.


Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit granted. The case is consolidated and a total of one hour is allotted for oral argument.


Summaries of

Pliva v. Mensing

U.S.
Dec 10, 2010
562 U.S. 1104 (2010)

In Mensing, the Supreme Court held that similar provisions of Minnesota and Louisiana product liability law "require a drug manufacturer that is or should be aware of its product's danger to label that product in a way that renders it reasonably safe."

Summary of this case from Couick v. Wyeth, Inc.
Case details for

Pliva v. Mensing

Case Details

Full title:PLIVA, INC., ET AL. v. GLADYS MENSING

Court:U.S.

Date published: Dec 10, 2010

Citations

562 U.S. 1104 (2010)
131 S. Ct. 817
178 L. Ed. 2d 550

Citing Cases

Stoddard v. Pliva USA, Inc.

On December 10, 2010, the United States Supreme Court granted certiorari in three cases involving the…

Schedin v. Ortho-McNeil-Janssen Pharmaceuticals

In addition to express pre-emption, "a court may find that Congress impliedly preempted such claims by…